EUVIMEDEUVIMED entdecken
Kohortenstudie

The Association Between Antibody Responses and Prolonged Viable Severe Acute Respiratory Syndrome Coronavirus 2 Shedding in Immunocompromised Patients: A Prospective Cohort Study

So Yun Lim, Jun-Won Kim, Ji Yeun Kim, Sung-Woon Kang, Choi-Young Jang, Euijin Chang, Jeong-Sun Yang, Kyung-Chang Kim, Hee-Chang Jang, Da Sol Kim, Younmin Shin, Joo-Yeon Lee und 1 weitere

The Journal of Infectious Diseases · 2024

DOI: 10.1093/infdis/jiad579 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift The Journal of Infectious Diseases, 2024. Verfasst von So Yun Lim und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul. Hauptthemen laut MEDLINE: Virus Shedding, Immunocompromised Host, COVID-19, SARS-CoV-2. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 13 Literaturangaben. Gefördert von: Korea National Institute of Health, National Research Foundation of Korea, Ministry of Science and ICT, Republic of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunocompromised patients with coronavirus disease 2019 were prospectively enrolled from March to November 2022 to understand the association between antibody responses and severe acute respiratory syndrome coronavirus 2 shedding. A total of 62 patients were analyzed, and the results indicated a faster decline in genomic and subgenomic viral RNA in patients with higher neutralizing and S1-specific immunoglobulin G (IgG) antibodies (both P < .001). Notably, high neutralizing antibody levels were associated with a significantly faster decrease in viable virus cultures (P = .04). Our observations suggest the role of neutralizing antibodies in prolonged virus shedding in immunocompromised patients, highlighting the potential benefits of enhancing their humoral immune response through vaccination or monoclonal antibody treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Virus SheddingImmunocompromised HostCOVID-19SARS-CoV-2Antibodies, ViralAntibodies, NeutralizingImmunoglobulin GHumansMaleProspective StudiesFemaleMiddle AgedAgedRNA, ViralAdultAntibody Formation

Stichwörter der Autor:innen

COVID-19SARS-CoV-2immunocompromisedvirus shedding

Substanzen

Antibodies, ViralAntibodies, NeutralizingImmunoglobulin GRNA, Viral

Autor:innen und Institutionen

  • Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul.
  • Division of Infectious Diseases, Department of Internal Medicine, National Medical Center, Seoul.
  • National Institute of Infectious Diseases, Korea National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju.
  • Office for Infection Control, Asan Medical Center, Seoul, Republic of Korea.

ORCID-Profile: Sung-Han Kim

Förderung

  • Korea National Institute of Health
  • National Research Foundation of Korea
  • Ministry of Science and ICT, Republic of Korea

Zitieren

APA

Lim, S. Y., Kim, J. W., Kim, J. Y., Kang, S. W., Jang, C. Y., Chang, E., Yang, J. S., Kim, K. C., Jang, H. C., Kim, D. S., Shin, Y., Lee, J. Y., & Kim, S. H. (2024). The Association Between Antibody Responses and Prolonged Viable Severe Acute Respiratory Syndrome Coronavirus 2 Shedding in Immunocompromised Patients: A Prospective Cohort Study. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiad579

Vancouver

Lim SY, Kim JW, Kim JY, Kang SW, Jang CY, Chang E, et al. The Association Between Antibody Responses and Prolonged Viable Severe Acute Respiratory Syndrome Coronavirus 2 Shedding in Immunocompromised Patients: A Prospective Cohort Study. The Journal of Infectious Diseases. 2024. doi:10.1093/infdis/jiad579

BibTeX
@article{Lim2024,
  author = {Lim, So Yun and Kim, Jun-Won and Kim, Ji Yeun and Kang, Sung-Woon and Jang, Choi-Young and Chang, Euijin and Yang, Jeong-Sun and Kim, Kyung-Chang and Jang, Hee-Chang and Kim, Da Sol and Shin, Younmin and Lee, Joo-Yeon and Kim, Sung-Han},
  title = {The Association Between Antibody Responses and Prolonged Viable Severe Acute Respiratory Syndrome Coronavirus 2 Shedding in Immunocompromised Patients: A Prospective Cohort Study},
  journal = {The Journal of Infectious Diseases},
  year = {2024},
  doi = {10.1093/infdis/jiad579}
}
Kostenlos starten →